The expansive, dense eelgrass beds that line much of the U.S. coastline provide invaluable habitat and other services to ...

A newly revealed molecular tug-of-war may have implications for better understanding how a multitude of diseases and ...

Mercury Bio, a biotechnology company advancing large-molecule therapeutics for neurodegenerative disease, and Meta-Flux, an AI-powered disease simulation company, have announced a strategic ...

Mount Sinai scientists developed V2P, a powerful new AI tool that predicts how specific DNA mutations translate into disease, ...

A new genetic mapping strategy reveals how entire networks of genes work together to cause disease, filling in the missing ...

Australian scientists have identified the key genetic drivers behind long COVID, revealing why some people continue to ...

In a world first, scientists from 24 countries have mapped the DNA of more than 233 different primate species, more than quadrupling the existing genetic data, providing crucial new insights into ...

Metabolic diseases, including type 2 diabetes (T2D), obesity, and metabolic syndrome, are a growing threat to global public health. More than 537 million adults currently live with T2D, and this ...

Rare neurological diseases offer unusually clear models for testing earlier diagnosis, precision treatment and long-term ...

Life expectancy in the best-performing countries has been increasing by three months per year every year since the early 1800s. Throughout most of human history, you had a roughly 50–50 chance of ...

Obesity is not a single disease. New research shows distinct biological phenotypes that explain why weight gain and treatment ...

Claire Huntington, a biotechnology major and class assistant, demonstrates how to apply a sample into gel in the Design to Data program within the Genome Center's Siegel Lab taught by Ashley Vater.